Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Implantable Cardiac Monitors Market, by Indication
1.4.2 North America Implantable Cardiac Monitors Market, by End User
1.4.3 North America Implantable Cardiac Monitors Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.1.3 Players Outlook for the Market
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Implantable Cardiac Monitors Market by Indication
3.1.1 North America Cardiac Arrhythmias Market by Country
3.1.2 North America Atrial Fibrillation Market by Country
3.1.3 North America Epilepsy & Unexplained Falls Market by Country
Chapter 4. North America Implantable Cardiac Monitors Market by End User
4.1.1 North America Hospitals Implantable Cardiac Monitors Market by Country
4.1.2 North America Ambulatory Surgery Centres (ASCs) Implantable Cardiac Monitors Market by Country
4.1.3 North America Cardiac Centre & Clinics Implantable Cardiac Monitors Market by Country
Chapter 5. North America Implantable Cardiac Monitors Market by Country
5.1 US Implantable Cardiac Monitors Market
5.1.1 US Implantable Cardiac Monitors Market by Indication
5.1.2 US Implantable Cardiac Monitors Market by End User
5.2 Canada Implantable Cardiac Monitors Market
5.2.1 Canada Implantable Cardiac Monitors Market by Indication
5.2.2 Canada Implantable Cardiac Monitors Market by End User
5.3 Mexico Implantable Cardiac Monitors Market
5.3.1 Mexico Implantable Cardiac Monitors Market by Indication
5.3.2 Mexico Implantable Cardiac Monitors Market by End User
5.4 Rest of North America Implantable Cardiac Monitors Market
5.4.1 Rest of North America Implantable Cardiac Monitors Market by Indication
5.4.2 Rest of North America Implantable Cardiac Monitors Market by End User
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental Analysis
6.1.4 Research & Development Expense
6.2 ABBOTT Laboratories
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional & Segmental Analysis
6.2.4 Research & Development Expense
6.3 Agilent Technologies
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Schiller AG
6.4.1 Company Overview
6.5 Abiomed, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expense
6.6 Jarvik Heart, Inc.
6.6.1 Company Overview
6.7 Berlin Heart GmbH
6.7.1 Company Overview
6.8 Astellas Pharma Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expense
6.9 Reliantheart Inc.
6.9.1 Company Overview
6.1 BIOTRONIK SE & CO. KG
6.10.1 Company Overview